Publications

PUBLICATIONS

2019


Incidence of Immune-Mediated Inflammatory Diseases Among Patients With Inflammatory Bowel Diseases in Denmark.
Burisch J, Jess T, Egeberg A.
Clin Gastroenterol Hepatol 2019, in press


Polymorphisms in the NFkB, TNF-alpha, IL-1beta, and IL-18 pathways are associated with response to anti-TNF therapy in Danish patients with inflammatory bowel disease.
Bank S, Julsgaard M, Abed OK, Burisch J, Broder Brodersen J, Pedersen NK, Gouliaev A, Ajan R, Nytoft Rasmussen D, Honore Grauslund C, Roug S, Galsgaard J, Sprogøe Høyer Finsen D, Lindby K; Danish IBD Genetics Working Group, Sørensen J, Larsen L, Rohr Andersen M, Brandslund I, Thomassen M, Green A, Bo Bojesen A, Bek Sørensen S, Vogel U, Andersen V.
Aliment Pharmacol Ther 2019, in press


Sex-based differences in the incidence of inflammatory bowel diseases-pooled analysis of population-based studies from the Asia-Pacific region.
Shah SC, Khalili H, Chen CY, Ahn HS, Ng SC, Burisch J, Colombel JF.
Aliment Pharmacol Ther 2019, in press


Does Eradication of Helicobacter Pylori Cause Inflammatory Bowel Disease?
Burisch J, Jess T.
Clin Gastroenterol Hepatol 2019, in press


Trends in hospitalisation rates for inflammatory bowel disease in western versus newly industrialised countries: a population-based study of countries in the Organisation for Economic Co-operation and Development.
King JA, Underwood FE, Panaccione N, Quan J, Windsor JW, Kotze PG, Ng SC, Ghosh S, Lakatos PL, Jess T, Panaccione R, Seow CH, Ben-Horin S, Burisch J, Colombel JF, Loftus EV Jr, Gearry R, Halfvarson J, Kaplan GG.
Lancet Gastroenterol Hepatol 2019, in press


Colorectal Cancer in Individuals With Familial Adenomatous Polyposis, Based on Analysis of the Danish Polyposis Registry.
Karstensen JG, Burisch J, Pommergaard HC, Aalling L, Højen H, Jespersen N, Schmidt PN, Bülow S.
Clin Gastroenterol Hepatol 2019, in press


Impact of Genes and the Environment on the Pathogenesis and Disease Course of Inflammatory Bowel Disease.

Zhao M, Burisch J.

Dig Dis Sci 2019, in press


Direct and Indirect Costs of Inflammatory Bowel Disease: Ten Years of Follow Up in a Danish Population-Based Inception Cohort.

Lo B, Vind I, Vester-Andersen MK, Bendtsen F, Burisch J.

J Crohns Colitis 2019, in press


Natural disease course of Crohn’s disease during the first five years after diagnosis in a European population-based inception cohort – an Epi-IBD study

Burisch J, Gediminas Kiudelis, Limas Kupcinskas, Hendrika Adriana Linda Kievit, Karina Winther Andersen, Vibeke Andersen, Riina Salupere, Natalia Pedersen, Jens Kjeldsen, Renata D'Incà, Daniela Valpiani, Doron Schwart, Selwyn Odes, Jóngerð Midjord, Kári Rubek Nielsen, Zsuzsanna Vegh, Peter L. Lakatos, Alina Toca, Svetlana Turcan, Konstantinos H. Katsanos, Dimitrios K. Christodoulou, Mathurin Fumery, Corinne Gower-Rousseau, Stefania Chetcuti Zammit, Pierre Ellul, Carl Eriksson, Jonas Halfvarson, Fernando Magro, Dana Duricova; Martin Bortlik, Alberto Fernandez, Vicent Hernandez, Sally Myers, Shaji Sebastian, Pia Oksanen, Pekka Collin, Adrian Goldis, Ravi Misra, Naila Arebi, Ioannis P. Kaimakliotis, Inna Nikulina, Elena Belousova, Marko Brinar, Silvija Čuković-Čavka, Ebbe Langholz, Munkholm P for the Epi-IBD group

Gut 2018, in press


Natural disease course of ulcerative colitis during the first five years of follow-up in a European population-based inception cohort – an Epi-IBD study

Johan Burisch, Konstantinos H. Katsanos, Dimitrios K. Christodoulou, Luisa Barros, Fernando Magro, Natalia Pedersen, Jens Kjeldsen, Zsuzsanna Vegh, Peter L. Lakatos, Carl Eriksson, Jonas Halfvarson, Mathurin Fumery, Corinne Gower-Rousseau, Marko Brinar, Silvija Čuković-Čavka, Inna Nikulina, Elena Belousova, Sally Myers, Shaji Sebastian, Gediminas Kiudelis, Limas Kupcinskas, Doron Schwartz, Selwyn Odes, Ioannis P. Kaimakliotis, Daniela Valpiani, Renata D'Incà, Riina Salupere, Stefania Chetcuti Zammit, Pierre Ellul, Dana Duricova, Martin Bortlik, Adrian Goldis, Hendrika Adriana Linda Kievit, Alina Toca, Svetlana Turcan, Jóngerð Midjord, Kári Rubek Nielsen, Karina Winther Andersen, Vibeke Andersen, Ravi Misra, Naila Arebi, Pia Oksanen, Pekka Collin, Luisa de Castro, Vicent Hernandez, Ebbe Langholz, Pia Munkholm for the Epi-IBD group

J Crohns Colitis 2019, in press


A 10-year follow-up study of the natural history of perianal Crohn’s disease in a Danish population-based inception cohort

Mirabella Zhao, Bobby Zhao Sheng Lo, Marianne Vester-Andersen, Ida Vind, Flemming Bendtsen, Johan Burisch

Inflamm Bowel Dis 2018, in press


Association between Inflammatory Bowel Disease and Parkinson’s Disease: a nationwide Swedish cohort study

Petra Weimers, Jonas Halfvarson, Michael C Sachs, Rachel Saunders-Pullman, Jonas F Ludvigsson,

Inga Peter*, Johan Burisch*, Ola Olén*

* contributed equally

Inflamm Bowel Dis. 2019 Jan 1;25(1):111-123


The Pathogenesis of Extraintestinal Manifestations: Implications for IBD research, diagnosis and therapy

Charlotte Hedin, Giorgios Bamias, Matthias Becker, Dominik Bettenworth, Johan Burisch, Pierre Ellul, Thomas Greuter, Anna Kagramanova, Kostas Katsanos, Yago Gonzalez Lama, Jochen Maul, Alexander Navarini, Uwe Pleyer, Tim Raine, Lluis Puig Sanz, Alain Schoepfer, Andy Stagg, Floris van Gaalen, Andrea van der Meulen, Stephan Vavricka, Florian Rieder

J Crohns Colitis 2018, in press


The association between inflammatory bowel disease and Parkinson’s disease: seek and you shall find?

Petra Weimers, Jonas Halfvarson, Michael C Sachs, Jonas F Ludvigsson, Inga Peter, Ola Olén, Johan Burisch

Gut. 2019 Jan;68(1):175-176.


Incidence and risk of inflammatory bowel disease in patients with psoriasis – a nationwide 20-year cohort study

Alexander Egeberg; Jacob P. Thyssen; Johan Burisch; Jean-Frederic Colombel

Journal of Investigative Dermatology 2018, in press


Frequency, treatment strategy and disease course of inflammatory bowel disease unclassified in a European population-based inception cohort – an Epi-IBD study

Johan Burisch, Stefania Chetcuti Zammit, Pierre Ellul, Alina Toca, Svetlana Turcan, Dana Duricova; Martin Bortlik, Karina Winther Andersen, Vibeke Andersen, Ioannis P. Kaimakliotis, Mathurin Fumery, Corinne Gower-Rousseau, Giulia Girardin, Daniela Valpiani, Adrian Goldis, Marko Brinar, Silvija Čuković-Čavka, Pia Oksanen, Pekka Collin, Luisa Barros, Fernando Magro, Ravi Misra, Naila Arebi, Carl Eriksson, Jonas Halfvarson, Hendrika Adriana Linda Kievit, Natalia Pedersen, Jens Kjeldsen, Sally Myers, Shaji Sebastian, Konstantinos H. Katsanos, Dimitrios K. Christodoulou, Jóngerð Midjord, Kári Rubek Nielsen, Gediminas Kiudelis, Limas Kupcinskas, Inna Nikulina, Elena Belousova, Doron Schwartz, Selwyn Odes, Riina Salupere, Amalia Carmona, Juan R Pineda, Zsuzsanna Vegh, Peter L. Lakatos, Ebbe Langholz, Pia Munkholm for the Epi-IBD group

Journal of Gastroenterology and Hepatology 2018, in press

2018


Changes in disease behaviour and location in patients with Crohn’s disease after seven years of follow-up: a Danish population-based inception cohort

Lo B, Vester-Andersen MK, Vind I, Prosberg M, Dubinsky M, Siegel C, Bendtsen F, Burisch J

J Crohns Colitis 2018;12:265–272


Systematic review and meta-analysis: assessment of factors affecting disability in inflammatory bowel disease and the reliability of the inflammatory bowel disease disability index

Lo B, Prosberg M, Gluud LL, Chan W, Leong R, Van der list E, Var der have M, Sarter H, Gower-Rousseau C,  Peyrin-Biroulet L, Vind I, Burisch J. Aliment Pharmacol Ther 2018;47:6–15.


Systematic review and meta-analysis of the Epidemiology of Inflammatory Bowel Disease in Racial and Ethnic Migrant groups

Ravi Misra, Omar Faiz, Pia Munkholm, Johan Burisch, Naila Arebi. World J Gastroenterol 2018, in press


Natural disease course of Crohn’s disease during the first five years after diagnosis in a European population-based inception cohort – an Epi-IBD study

Burisch J, Gediminas Kiudelis, Limas Kupcinskas, Hendrika Adriana Linda Kievit, Karina Winther Andersen, Vibeke Andersen, Riina Salupere, Natalia Pedersen, Jens Kjeldsen, Renata D'Incà, Daniela Valpiani, Doron Schwart, Selwyn Odes, Jóngerð Midjord, Kári Rubek Nielsen, Zsuzsanna Vegh, Peter L. Lakatos, Alina Toca, Svetlana Turcan, Konstantinos H. Katsanos, Dimitrios K. Christodoulou, Mathurin Fumery, Corinne Gower-Rousseau, Stefania Chetcuti Zammit, Pierre Ellul, Carl Eriksson, Jonas Halfvarson, Fernando Magro, Dana Duricova; Martin Bortlik, Alberto Fernandez, Vicent Hernandez, Sally Myers, Shaji Sebastian, Pia Oksanen, Pekka Collin, Adrian Goldis, Ravi Misra, Naila Arebi, Ioannis P. Kaimakliotis, Inna Nikulina, Elena Belousova, Marko Brinar, Silvija Čuković-Čavka, Ebbe Langholz, Munkholm P for the Epi-IBD group. Gut 2018, in press


European Crohn’s and Colitis Organisation Topical Review on Treatment Withdrawal (‘Exit Strategies’) in Inflammatory Bowel Disease

Doherty, Glen; Katsanos, Konstantinos H; Burisch, Johan; Allez, Matthieu; Papamichael, Konstantinos; Stallmach, Andreas; Mao, Ren; Berset, Ingrid Prytz; Gisbert, Javier P; Sebastian, Shaji; Kierkuś, Jarosław; Lopetuso, Loris; Szymanska, Edyta; Louis, Edouard

J Crohns Colitis 2018;12:17–31.


The importance of detecting Irritable bowel-like symptoms in IBD patients

Weimers P, Burisch J.

J Crohns Colitis. 2018 Mar 28;12(4):385-386.


Exposome and diet

Seidelin JB, Burisch J.

In: Ding NS, Cruz P De, eds. Biomarkers in Inflammatory Bowel Diseases – Combining Science with Clinical Practice. 1st ed. Springer Publishing; 2018.


Validation of the United Registries for Clinical Assessment and Research (UR-CARE), a European online registry for clinical care and research in Inflammatory Bowel Disease

Johan Burisch, Javier P. Gisbert, Britta Siegmund, Dominik Bettenworth, Sandra Bohn Thomsen, Isabelle Cleynen6, Anneline Cremer7, Nik John Sheng Ding8, Federica Furfaro9, Michail Galanopoulos, Philip Christian Grunert, Jurij Hanzel, Tamara Knezevic Ivanovski, Eduards Krustins, Nurulamin Noor, Neil O'Morain, Iago Rodríguez-Lago, Michael Scharl, Julia Tua, Mathieu Uzzan, Nuha Ali Yassin, Filip Baert, Ebbe Langholz

J Crohns Colitis. 2018 Apr 27;12(5):532-537


Vitamin D deficiency in a European Inflammatory Bowel disease inception cohort: An Epi-IBD study

Stefania Chetcuti Zammit, Pierre Ellul, Giulia Girardin, Danilea Valpiani, Kári Rubek Nielsen, Jóngerð Olsen, Adrian Goldis, Daniela Lazar, Olga Shonová, Shaji Sebastian, Emma Whitehead, Amalia Carmona, Jesus Martinez-Cadilla, Jens Frederik Dahlerup, Hendrika Adriana Linda Kievit, Niels Thorsgaard, Konstantinos H. Katsanos, Dimitrios K. Christodoulou, Fernando Magro, Riina Salupere, Natalia Pedersen, Jens Kjeldsen, Katrine Carlsen, Kaimaklioti Ioannis, Daniel Bergemalm, Jonas Halfvarson, Dana Duricova, Martin Bortlik, Pekka Collin,  Pia Oksanen, Gediminas Kiudelis, Limas Kupcinskas, Karen Kudsk, Vibeke Andersen, Colm O'Morain, Yvonne Bailey, Doron Schwartz,   Shmuel Odes, Sven Almer, Naila Arebi, Ravi Misra, Silvija Čuković-Čavka, Marko Brinar, Pia Munkholm, Zsuzsanna Vegh, Johan Burisch

Eur J Gastroenterol Hepatol. 2018 Nov;30(11):1297-1303.


Efficacy of different fecal transplant protocols for the treatment of recurrent Clostridium difficile infection: a systematic review and metanalysis

Gianluca Ianiro, Marcello Maida, Johan Burisch, Claudia Simonelli, Antonio Gasbarrini, Giovanni Cammarota

United European Gastroenterol J. 2018 Oct;6(8):1232-1244.


Disease activity, steroid use and extraintestinal manifestations are associated with increased disability in patients with inflammatory bowel disease using the inflammatory bowel disease disability index: a cross-sectional multicentre cohort study.

Bobby Zhao Sheng Lo, Mette Bykærholm Julsgaard, Marianne Kajbæk Vester-Andersen, Ida Vind, Johan Burisch

Eur J Gastroenterol Hepatol. 2018 Oct;30(10):1130-1136


The sex ratio of inflammatory bowel disease varies according to age at onset: results from a worldwide analysis

Shailja C. Shah*, Hamed Khalili*, Corinne Gower-Rousseau, Ola Olen, Eric Benchimol, Kári R. Nielsen, Elsebeth Lynge, Hyeong Sik Ahn, Da Yeong Yoon, Paul Brassard, Maria Vutcovici, Alain Bitton, Charles Bernstein, Desmond Leddin, Hala Tamim, Satimai Aniwan, Chung Yu Chen, Tryggvi Stefansson, Edward V. Loftus, Jr., Bjørn Moum, Whitney Tang, Siew Ng, Richard Gearry, Brankica Sincic, Sally Bell, Peter L. Lakatos, Zsuzsanna Végh, Claudia Ott, Gilaad Kaplan, Johan Burisch*, Jean-Frederic Colombel*

* contributed equally

Gastroenterology. 2018 Oct;155(4):1079-1089.


IBD2020 Global Forum: Results of an International Patient Survey on Quality of Care

Peter Irving, Johan Burisch, Richard Driscoll, Mats Olsson, John R. Fullarton, Barry S. Rodgers

Gray, Simon P.L. Travis

Intest Res. 2018 Oct;16(4):537-545.


2017


Using e-health strategies in delivering dietary and other therapies in IBS and IBD

Ankersen DV, Carlsen K, Marker D, Munkholm P, Burisch J. J Gastroenterol Hepatol 2017;32(Supplement S1):27–31.


Genetically determined high activity of IL-12 and IL-18 in ulcerative colitis and TLR5 in Crohns disease were associated with non-response to anti-TNF therapy

Steffen Bank, Paal Skytt Andersen, Johan Burisch, Natalia Pedersen, Stine Roug, Julied Galsgaard, Stine Ydegaard Turino, Jacob Broder Brodersen, Shaista Rashid, Britt Kaiser Rasmussen, Sara Avlund, Thomas Bastholm Olesen, Hans Jürgen Hoffmann, Bjørn Andersen Nexø, Jacob Sode, Ulla Vogel and Vibeke Andersen. Pharmacogenomics J. 2017, in press


European Crohn's and Colitis Organisation Topical Review on environmental factors in IBD

Maaser C, Langholz E, Gordon H, Burisch J, Ellul P, Hernández Ramirez V, Karakan T, Katsanos KH, Krustins E, Levine A, Mantzaris GJ, O'Morain C, Saritas Yuksel E, Strid H, Annese V. J Crohns Colitis 2017 2017;11:905–920.


What defines in treating patients with inflammatory bowel disease?

Theede K, Burisch J. Expert Rev Clin Immunol. 2017 Jul;13(7):645-647


Inflammatory Bowel Diseases in Faroese-born Danish residents and their offspring: is the risk of IBD driven by genetic or environmental factors?

Hammer T, Lophaven SN, Nielsen KR, 3, von Euler-Chelpin M, Weihe P, Munkholm P, Burisch J, Lynge E. Aliment Pharmacol Ther 2017;45(8):1107–14.


Letter: determining the dominant role of environmental factors in UC development-Authors' reply.

Hammer T, Lophaven SN, Burisch J, Lynge E. Aliment Pharmacol Ther. 2017 Jul;46(1):78-79.


The incidence of inflammatory bowel disease in Denmark 1980-2013: a nationwide cohort study

Lophaven SN, Lynge E, Burisch J. Aliment Pharmacol Ther 2017;45:961–972


Third European Evidence-Based Consensus on Diagnosis and Management Of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-Intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, And Ileo-Anal Pouch Disorders

Fernando Magro, Paolo Gionchetti, Rami Eliakim, Sandro Ardizzone, Alessandro Armuzzi, Manuel Barreiro-de Acosta, Johan Burisch, Krisztina B. Gecse, Ailsa L. Hart, Pieter Hindryckx, Cord Langner, Jimmy K. Limdi, Gianluca Pellino, Edyta Sylvwia Zagórowicz, Tim Raine, Marcus Harbord, Florian Rieder, for the European Crohn’s and Colitis Organisation (ECCO). J Crohns Colitis. 2017 Jun 1;11(6):649-670.


Systematic review with meta-analysis: Proximal disease extension in limited ulcerative colitis

Giulia Roda, Neeraj Narula, Rachel Pinotti, Alexandros Skamnelos, Konstantinos H. Katsanos, Ryan Ungaro, Johan Burisch, Joana Torres, Jean-Frederic Colombel. Aliment Pharmacol Ther 2017;45:1481–1492


Low FODMAP diet reduces irritable bowel symptoms and improves quality of life in patients with inflammatory bowel disease in a randomized controlled trial

Natalia Pedersen, Dorit Vedel Andersen, Maria Felding, Zsuzsanna Végh, Johan Burisch, Jens Rikardt Andersen and, Pia Munkholm.

World J Gastroenterol 2017; 23(18): 3356-3366


Proximal disease extension in patients with limited ulcerative colitis: a Danish population-based inception cohort

Burisch J, Ungaro R, Vind I, Prosberg MV, Bendtsen F, Colombel J-F, Vester-Andersen MK. J Crohns Colitis. 2017 Oct 1;11(10):1200-1204


Occurrence of anaemia in the first year of inflammatory bowel disease in a European population-based inception cohort – An ECCO-EpiCom study

Burisch J,  Vegh Z, Katsanos KH, Christodoulou D,  Lazar D, Goldis A, O’Morain C, Fernandez A,  Pereira S, Myers S, Sebastian S, Pedersen N, Olsen J, Nielsen KR, Schwartz D, Odes S, Almer S, Halfvarson J, Turk N, Cukovic-Cavka S, Nikulina I, Belousova E, Duricova D, Bortlik M, Shonová O, Salupere R, Barros L, Magro F, Jonaitis L, Kupcinskas L, Turcan S, Kaimakliotis I, Ladefoged  K, Kudsk K, Andersen V, Vind I, Thorsgaard N, Oksanen P, Collin P, Dal Piaz G, Santini A, Niewiadomski O, Bell S, Moum B, Arebi N, Kjeldsen J, Carlsen K, Langholz E, Lakatos PL, Munkholm  P, Gerdes LU, Dahlerup JF. J Crohns Colitis. 2017 Oct 1;11(10):1213-1222


The Organisation and needs of the young sections belonging to UEG National Societies: results from a survey across Europe

Gianluca Ianiro, Valeria Castro, Werner Dolak, Madalina Ilie, Grainne Holleran, Maciej Salaga, Yasmijn van Herwaarden, Johan Burisch for the UEG Young Talent Group. United European Gastroenterol J. 2017 Aug;5(5):750-755


Whats “App-ening” – the help of new technologies in nutrition in digestive diseases

Dorit Vedel Ankersen, Petra Weimers, Johan Burisch. Curr Opin Clin Nutr Metab Care. 2017 Sep;20(5):426-431


The complexity of evaluating and increasing adherence in inflammatory bowel disease.

Weimers P, Burisch J, Munkholm P. Rev Esp Enferm Dig. 2017 Aug;109(8):539-541


How to start a Young GI Section in your country - A cookbook

Valeria Castro , Grainne Holleran , Gianluca Ianiro , Maciej Salaga , Madalina Ilie  and Johan Burisch  for the Young Talent Group, UEG. United European Gastroenterol J. 2017 Oct; 5(6): 910–912.


2016


The First European Evidence-Based Consensus on Extra-Intestinal Manifestations in Inflammatory Bowel Disease

Marcus Harbord, Vito Annese, Stephan Vavricka, Matthieu Allez, Manuel Barreiro De Acosta, Kirsten Borberg, Johan Burisch, Martine De Vos, Anne-Marie De Vries, Andrew Dick, Pascal Juillerat, Tom Karlsen, Ioannis Koutroubakis, Peter Lakatos, Tim Orchard, Pavol Papay, Tim Raine, Max Reinshagen, Diamant Thaci, Herbert Tilg, Franck Carbonne, for the European Crohn’s and Colitis Organization (ECCO). J Crohns Colitis 2016;10(3):239–54


The Faroese IBD study -  Incidence of Inflammatory Bowel Diseases in 54-years’ of population-based data

Turid Hammer, Kári R. Nielsen, Pia Munkholm, Johan Burisch, Elsebeth Lynge. J Crohns Colitis 2016;10(8):934–42


What Makes For A Good Mentor?

Iris Dotan, Johan Burisch. United European Gastroenterol J. 2016 Apr;4(2):320


Follow-up of patients with functional bowel symptoms treated with a low FODMAP diet.

Louise Maagaard, Zsuzsanna Végh, Johan Burisch, Lisbeth Jensen, Natalia Pedersen, Pia Munkholm. World J Gastroenterol. 2016 Apr 21;22(15):4009-19.


Pre-clinical disease and preventive strategies in IBD: perspectives, challenges, and opportunities

Joana Torres, Johan Burisch, Mark Riddle, Marla Dubinsky, Jean-Frederic Colombel. Gut 2016;65(7):1061–9.


Faecal calprotectin measured by IBD patients at home - a new clinical tool

Kristoffer Kofod Vinding, Henriette Elsberg, Tine Thorkilgaard, Dorte Marker, Katrine Carlsen, Johan Burisch, P Munkholm. Inflamm Bowel Dis. 2016 Feb;22(2):336-44


2015


Polymorphisms in the Toll-like receptor and the IL-23/IL-17 pathways were associated with susceptibility to inflammatory bowel disease in a Danish cohort

Steffen Bank, Paal Skytt Andersen, Johan Burisch, Natalia Pedersen, Stine Roug, Julied Galsgaard, Stine Ydegaard Turino, Jacob Broder Brodersen, Shaista Rashid, Britt Kaiser Rasmussen, Sara Avlund, Thomas Bastholm Olesen, Hans Jürgen Hoffmann, Marianne Kragh Thomsen, Vibeke Østergaard Thomsen, Morten Frydenberg, Bjørn Andersen Nexø, Jacob Sode, Ulla Vogel and Vibeke Andersen

PLoS One. 2015 Dec 23;10(12):e0145302


Costs and resource utilization during the initial year after diagnosis in a European inflammatory bowel disease inception cohort – An ECCO-EpiCom study

Burisch J, Vardi H, Pedersen N, Turk N, Cukovic-Cavka S, Kaimakliotis I, Duricova D,  Shonová O, Vind I, Avnstrøm S, Thorsgaard N, Krabbe S, Andersen V, Dahlerup JF, Kjeldsen J, Salupere R, Olsen J, Nielsen KR, Manninen P, Collin P, Katsanos KH, Tsianos EV, Ladefoged K, Lakatos L, Bailey Y, O’Morain C, Schwartz D, Lupinacci G, De Padova A, Jonaitis L, Kupcinskas L, Turcan S, Barros LF, Magro F, Lazar D, Goldis A, Nikulina I, Belousova E, Fernandez A, Hernandez V, Almer S, Halfvarson J, Tsai HH, Sebastian S, Friger M, Greenberg D, Lakatos PL, Langholz E, Odes S and Munkholm P for the EpiCom-group. Inflamm Bowel Dis. 2015 Jan;21(1):121-31


[Editorial] Environment and invironment in inflammatory bowel disease: partners in crime

Lakatos PL, Burisch J. Gut 2015;64(7):1009-10


The epidemiology of inflammatory bowel disease

Burisch J, Munkholm P. Scand J Gastroenterol. 2015 Aug;50(8):942-51


Rejuvenating UEG: The Young Talent Group and the Young GI Network

Burisch J. United European Gastroenterol J. 2015 Feb;3(1):99.


Treatment steps, surgery and hospitalization rates during the first year of follow-up in patients with inflammatory bowel diseases from the 2011 ECCO-EpiCom inception cohort

Z Vegh, J Burisch, N Pedersen, I Kaimakliotis, D Duricova, M Bortlik, Avnstrøm S, K Kofod Vinding, J Olsen, KR Nielsen, KH Katsanos, EV Tsianos, L Lakatos, D Schwartz, S Odes, G Lupinacci, A De Padova, L Jonaitis, L Kupcinskas, S Turcan, L F Barros, F Magro, D Lazar, A Goldis, A Fernandez, V Hernandez, O Niewiadomski, S Bell, P Munkholm and P L Lakatos for the EpiCom-group. J Crohns Colitis. 2015 Sep;9(9):747-53.


Effectiveness of anti-tumour necrosis factor-α therapy in Danish patients with inflammatory bowel diseases.

Steffen Bank, Paal Skytt Andersen, Johan Burisch, Natalia Pedersen, Stine Roug, Julie Galsgaard, Stine Ydegaard Turino, Jacob Broder Brodersen, Shaista Rashid, Britt Kaiser Rasmussen, Sara Avlund, Thomas Bastholm Olesen, Hans Jürgen Hoffmann, Marianne Kragh Thomsen, Vibeke Østergaard Thomsen, Bjørn Andersen Nexø, Ulla Vogel and Vibeke Andersen. Dan Med J 2015;62(3): A4994


2014


East-West gradient in the incidence of inflammatory bowel disease in Europe – the first ECCO-EpiCom inception cohort

Burisch J, Pedersen N, Cukovic-Cavka S, Brinar M, Kaimakliotis I, Duricova D, Shonová O, Vind I, Avnstrøm S, Thorsgaard N, Andersen V, Krabbe S, Dahlerup JF, Salupere R, Nielsen KR, Olsen J, Manninen P, Collin P, Tsianos EV, Katsanos KH, Ladefoged K, Lakatos L, Björnsson E, Ragnarsson G, Bailey Y, Odes S, Schwartz D, Martinato M, Lupinacci G, Milla M, De Padova A, D'Incà R, Beltrami M, Kupcinskas L, Kiudelis G, Turcan S, Tighineanu O, Mihu I, Magro F, Barros LF, Goldis A, Lazar D, Belousova E, Nikulina I, Hernandez V, Martinez-Ares D, Almer S, Zhulina Y, Halfvarson J, Arebi N, Sebastian S, Lakatos PL, Langholz E, Munkholm P, for the EpiCom-group.

Gut 2014;63(4):588–97


Initial disease course and treatment in an inflammatory bowel disease inception cohort in Europe – The ECCO-EpiCom cohort

Burisch J, Pedersen N, Cukovic-Cavka S, Turk N, Kaimakliotis I, Duricova D, Shonová O, Vind I, Avnstrøm S, Thorsgaard N, Krabbe S, Andersen V, Dahlerup JF, Kjeldsen J Salupere R, Olsen J, Nielsen KR, Manninen P, Collin P, Katsanos KH, Tsianos EV, Ladefoged K, Lakatos L, Bailey Y, O’Morain C, Schwartz D, Odes S, Martinato M, Lombardini S, Jonaitis L, Kupcinskas L, Turcan S, Barros LF, Magro  F, Lazar D, Goldis A, Nikulina I, Belousova E, Fernandez A, Hernandez V, Almer S, Zhulina Y, Halfvarson J, Tsai HH, Sebastian S, Lakatos PL, Langholz E and Munkholm P for the EpiCom-group.

Inflamm Bowel Dis 2014;20(1):36–46.


Environmental factors in a population-based inception cohort of inflammatory bowel disease patients in Europe – An ECCO-EpiCom study.

Burisch J, Pedersen N, Cukovic-Cavka S, Turk N, Kaimakliotis I, Duricova D, Bortlik M, Shonová O, Vind I, Avnstrøm S, Thorsgaard N, Krabbe S, Andersen V, Dahlerup JF, Kjeldsen J, Salupere R, Olsen J, Nielsen KR, Manninen P, Collin P, Katsanos KH, Tsianos EV, Ladefoged K, Lakatos L, Ragnarsson G, Björnsson E, Bailey Y, O’Morain C, Schwartz D, Odes S, Giannotta M, Girardin G, Kiudelis G, Kupcinskas L, Turcan S, Barros L, Magro F, Lazar D, Goldis A, Nikulina I, Belousova E, Martinez-Ares D, Hernandez V, Almer S, Zhulina Y, Halfvarson J, Arebi N, Tsai HH, Sebastian S, Lakatos P, Langholz E and Munkholm P for the EpiCom-group

J Crohns Colitis. 2014 Jul 1;8(7):607-16


Crohn’s disease and ulcerative colitis – occurrence, course and prognosis during the 1st year of disease in a European population-based inception cohort

Burisch J. Dan Med J 2014;61(1): B4778


Health care and patients' education in a European inflammatory bowel disease inception cohort – An ECCO-EpiCom study

Burisch J, Vegh Z, Pedersen N, Cukovic-Cavka S, Turk N, Kaimakliotis I, Duricova D, Bortlik M, Shonová O, Thorsgaard N, Krabbe S, Andersen V, Dahlerup JF, Kjeldsen J Salupere R, Olsen J, Nielsen KR, Manninen P, Collin P, Katsanos KH, Tsianos EV, Ladefoged K, Ragnarsson G, Björnsson E, Bailey Y, O’Morain C Schwartz D, Odes S, Politi P, Santini A, Kiudelis G, Kupcinskas L, Turcan S, Barros LF, Magro  F, Lazar D, Goldis A, Nikulina I, Belousova E, Fernandez A, Sanroman L , Almer S, Zhulina Y, Halfvarson J, Arebi N, Houston Y, Sebastian S, Langholz E, Lakatos PL and Munkholm P for the EpiCom-group. J Crohns Colitis 2014 Aug 1;8(8):811-8.


Health related quality of life improves during one year of medical and surgical treatment in a European population-based inception cohort of patients with inflammatory bowel disease – An ECCO-EpiCom study

Burisch J, Weimers P, Pedersen N, Cukovic-Cavka S, Vucelic B, Kaimakliotis I, Duricova D, Bortlik M, Shonová O, Vind I, Avnstrøm S, Thorsgaard N, Krabbe S, Andersen V, Dahlerup JF, Kjeldsen J Salupere R, Olsen J, Nielsen KR, Manninen P, Collin P, Katsanos KH, Tsianos EV, Ladefoged K, Lakatos L, Ragnarsson G, Björnsson E, Bailey Y, O’Morain C Schwartz D, Odes S, Valpiani D, Boni MC, Jonaitis L, Kupcinskas L, Turcan S, Barros LF, Magro  F, Lazar D, Goldis A, Nikulina I, Belousova E, Fernandez A, Sanroman L , Almer S, Zhulina Y, Halfvarson J, Arebi N, Diggory T, Sebastian S, Lakatos PL, Langholz E and Munkholm P for the EpiCom-group. J Crohns Colitis 2014 Sep 1;8(9):1030-42.


Associations between functionel polymorphisms in the NFkB signalling pathway and response to anti-TNF treatment in Danish patients with inflammatory bowel disease

Steffen Bank, Paal Skytt Andersen, Johan Burisch, Natalia Pedersen, Stine Roug, Julie Galsgaard, Stine Ydegaard Turino, Jacob Broder Brodersen, Shaista Rashid, Britt Kaiser Rasmussen, Sara Avlund, Thomas Bastholm Olesen, Hans Jürgen Hoffmann, Marianne Kragh Thomsen, Vibeke Ø Thomsen, Morten Frydenberg, Jacob Sode, Bjørn Andersen Nexø, Ulla Vogel and Vibeke Andersen. Pharmacogenomics J. 2014 Dec;14(6):526-34.


Ehealth monitoring in irritable bowel syndrome patients treated with low fermentable oligo-, di-, mono-saccharides and polyols diet

Natalia Pedersen, Zsuzsanna Vegh, Johan Burisch, Lisbeth Jensen, Dorit Vedel Andersen, Maria Felding, Nynne Nyboe Andersen, Pia Munkholm. World J Gastroenterol 2014 20(21):6680-6684


eHealth: Individualisation of  MMX mesalazine treatment and optimization of disease course via a self-managed web-based solution in active ulcerative colitis

Natalia Pedersen, Peter Thielsen, Lars Martinsen, Mette Bennedsen, Anne Haaber, Ebbe Langholz, Zsuzsanna Végh, Dana Duricova, Tine Jess, Sally Bell, Johan Burisch, Pia Munkholm. Inflamm Bowel Dis. 2014 Dec;20(12):2276-85.


Age-related differences in presentation and course of inflammatory bowel disease: An update from the  population-based literature

Dana Duricova*, Johan Burisch*, Tine Jess, Corinne Gower-Rousseau, Peter L. Lakatos on Behalf of ECCO-EpiCom

* contributed equally. J Crohns Colitis. 2014 Nov 1;8(11):1351-61


Polymorphisms in the inflammatory pathway genes TLR2, TLR4, TLR9, LY96, NFKBIA, NFKB1, TNFA, TNFRSF1A, IL6R, IL10, IL23R, PTPN22, and PPARG are associated with susceptibility of inflammatory bowel disease in a Danish cohort

Steffen Bank, Paal Skytt Andersen, Johan Burisch, Natalia Pedersen, Stine Roug, Julie Galsgaard, Stine Ydegaard Turino, Jacob Broder Brodersen, Shaista Rashid, Britt Kaiser Rasmussen, Sara Avlund, Thomas Bastholm Olesen, Hans Jürgen Hoffmann, Marianne Kragh Thomsen, Vibeke Ø Thomsen, Morten Frydenberg, Bjørn Andersen Nexø, Jacob Sode, Ulla Vogel and Vibeke Andersen. PLoS One. 2014 Jun 27;9(6):e98815


Incidence and initial disease course of inflammatory bowel diseases in 2011 in Europe and Australia: Results of the 2011 ECCO-EpiCom inception cohort

Z Vegh, J Burisch, N Pedersen, I Kaimakliotis, D Duricova, I Vind, K K Vinding,  J Olsen, KR Nielsen, KH Katsanos, EV Tsianos, L Lakatos, D Schwartz, S Odes, R D’Incà, S Lombardini, L Jonaitis, L Kupcinskas, S Turcan, O Tighineanu, I Mihu, L F Barros, F Magro, D Lazar, A Goldis, A Fernandez, V Hernandez, S Bell, O Niewiadomski, E Langholz, P Munkholm and P L Lakatos for the EpiCom-group

J Crohns Colitis. 2014 Nov 1;8(11):1506-15.


Ehealth: Low FODMAP and polyols vs Lactobacilus rhamnosus GG in irritable bowel syndrome

Natalia Pedersen, Nynne Nyboe Andersen, Zsuzsanna Végh, Lisbeth Jensen, Dorit Vedel Andersen, Maria Felding, Mette Hestetun, Johan Burisch, Pia Munkholm. World J Gastroenterol. 2014 Nov 21;20(43):16215-26.


2009-2013


A new rapid home test for Faecal Calprotectin in Ulcerative Colitis

Margarita Elkjaer, Johan Burisch, Vibeke Voxen Hansen, Birgit Deibjerg Kristensen, Jens-Kristian

Slott Jensen, Pia Munkholm. Aliment Pharmacol Ther 2009 31(2):323-30


Development of a Web-based concept for patients with Ulcerative Colitis and 5-Aminosalicylic acid treatment.

Margarita Elkjaer, Johan Burisch, Søren Avnstrøm, Elsebeth Lynge, Pia Munkholm. Eur J Gastroenterol Hepatol 2010 22(6):695-704


E-health empowers patients with Ulcerative Colitis through web-guided concept Constant-care. Running head: The web-guided concept Constant-care in UC

Margarita Elkjaer, Mary Shuhaibar, Johan Burisch, Yvonne Bailey, Hanne Scherfig, Birgit Laugesen, Søren Avnstrøm, Ebbe Langholz, Colm O´Morain,  Elsebeth Lynge, Pia Munkholm. Gut. 2010 Dec;59(12):1652-61.


Construction and validation of a web-based epidemiological database in Europe

Burisch J, Cukovic-Cavka S, Kaimakliotis I, Shonová O, Andersen V, Dahlerup JF, Elkjaer M, Langholz E, Pedersen N, Salupere R, Kolho KL, Manninen P, Lakatos PL, Shuhaibar M, Odes S, Martinato M, Mihu I, Magro F, Belousova E, Fernandez A, Almer S, Halfvarson J, Hart A, Munkholm P. for the EpiCom-group. J Crohns Colitis. 2011 Aug;5(4):342-9.


E-Health: Individualization of Infliximab Treatment and Disease Course via Self-managed Web-based Solution in Crohn's Disease.

Natalia Pedersen, Margarita Elkjaer, Dana Duricova, Johan Burisch, Christian Dobrzanski, Nynne Nyboe Andersen, Tine Jess, Flemming Bendtsen, Ebbe Langholz, Salvatore Leotta, Torben Knudsen, Niels Thorsgaard, Pia Munkholm. Aliment Pharmacol Ther. 2012 Nov 12;36(9):840–9.


The burden of Inflammatory Bowel Disease in Europe

Johan Burisch, Tine Jess, Matteo Martinato, Peter L Lakatos on behalf of ECCO-EpiCom. J Crohns Colitis. 2013 May 1;7(4):322-37.


Inflammatory bowel disease epidemiology

Burisch J, Munkholm P. Curr Opin Gastroenterol 2013 May 20;29(4):357–62

JOHAN BURISCH MD,PhD

Copyright @ All Rights Reserved